182
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Does a Healthy Weight Body Mass Index at Onset of Idiopathic Intracranial Hypertension Change the Outcomes? A United Kingdom Prospective Cohort Study

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Received 02 Oct 2023, Accepted 08 Apr 2024, Published online: 22 Apr 2024

References

  • Yiangou A, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms. Nat Rev Neurol. 2023;19(12):769–785. doi:10.1038/s41582-023-00893-0.
  • Adderley NJ, Subramanian A, Nirantharakumar K, et al. Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;76(9):1088–1098. doi:10.1001/jamaneurol.2019.1812.
  • Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–1100. doi:10.1136/jnnp-2017-317440.
  • Grech O, Clouter A, Mitchell JL, et al. Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure. Brain Commun. 2021;3:fcab202. doi:10.1093/braincomms/fcab202.
  • Thaller M, Homer V, Hyder Y, et al. The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol. 2023;270(2):851–863. doi:10.1007/s00415-022-11402-6.
  • Adderley NJ, Subramanian A, Perrins M, Nirantharakumar K, Mollan SP, Sinclair AJ. Headache, opiate use, and prescribing trends in women with idiopathic intracranial hypertension: a population-based matched cohort study. Neurology. 2022;99:e1968–1978. doi:10.1212/WNL.0000000000201064.
  • Mollan SP, Wakerley BR, Alimajstorovic Z, et al. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):118. doi:10.1186/s10194-021-01321-8.
  • Hyder YF, Homer V, Thaller M, et al. Defining the phenotype and prognosis of people with idiopathic intracranial hypertension after cerebrospinal fluid diversion surgery. Am J Ophthalmol. 2023;250:70–81. doi:10.1016/j.ajo.2023.01.016.
  • Bruce BB, Kedar S, Van Stavern GP, Corbett JJ, Newman NJ, Biousse V. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology. 2010;74(22):1827–1832. doi:10.1212/WNL.0b013e3181e0f838.
  • World Health Organisation. Body mass index – BMI [Online]. https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations. 2010. Accessed July 27, 2023.
  • Consultation WHOE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-3.
  • National Institute for Health and Care Excellence. Obesity: identification, assessment and management clinical guideline [CG189]. 2014.
  • Hornby C, Botfield H, O’Reilly MW, et al. Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy X-ray absorptiometry scanning. Neuroophthalmology. 2018;42:99–104. doi:10.1080/01658107.2017.1334218.
  • Hornby C, Mollan SP, Botfield H, O’Reilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38:522–530. doi:10.1097/WNO.0000000000000684.
  • Fric R, Pripp AH, Eide PK. Cardiovascular risk factors in Chiari malformation and idiopathic intracranial hypertension. Brain Behav. 2017;7:e00677. doi:10.1002/brb3.677.
  • Thaller M, Mytton J, Wakerley BR, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: evaluation of births and fertility through the hospital episode statistics dataset. BJOG. 2022;129(12):2019–2027. doi:10.1111/1471-0528.17241.
  • Alimajstorovic Z, Pascual-Baixauli E, Hawkes CA, et al. Cerebrospinal fluid dynamics modulation by diet and cytokines in rats. Fluids Barriers CNS. 2020;17(1):10. doi:10.1186/s12987-020-0168-z.
  • Westgate CS, Botfield HF, Alimajstorovic Z, et al. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. 2021;6:e145346. doi:10.1172/jci.insight.145346.
  • Westgate CSJ, Markey K, Mitchell JL, et al. Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension. Eur J Endocrinol. 2022;187:323–333. doi:10.1530/EJE-22-0108.
  • O’Reilly MW, Westgate CS, Hornby C, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4. doi:10.1172/jci.insight.125348.
  • Thaller M, Sinclair AJ, Tsermoulas G, Mollan SP. Considerations from venous stenosis to metabolic underpinnings in idiopathic intracranial hypertension. Cephalalgia. 2023;43(6):3331024231184445. doi:10.1177/03331024231184445.
  • Fargen KM, Coffman S, Torosian T, Brinjikji W, Nye BL, Hui F. “Idiopathic” intracranial hypertension: an update from neurointerventional research for clinicians. Cephalalgia. 2023;43(4):3331024231161323. doi:10.1177/03331024231161323.
  • Mollan SP, Tahrani AA, Sinclair AJ. The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight. Neurol Clin Pract. 2021;11:e504–e507. doi:10.1212/CPJ.0000000000001063.
  • Thaller M, Tsermoulas G, Sun R, Mollan SP, Sinclair AJ. Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2021;92(7):795–797. doi:10.1136/jnnp-2020-325519.
  • Mollan SP, Mitchell JL, Ottridge RS, et al. Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol. 2021;78(6):678–686. doi:10.1001/jamaneurol.2021.0659.
  • Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341(jul07 2):c2701. doi:10.1136/bmj.c2701.
  • Mollan SP, Mitchell JL, Yiangou A, et al. Association of amount of weight lost after bariatric surgery with intracranial pressure in women with idiopathic intracranial hypertension. Neurology. 2022;99:e1090–e1099. doi:10.1212/WNL.0000000000200839.
  • Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71(6):693–701. doi:10.1001/jamaneurol.2014.133.
  • Sharma B, Seervi N, Sharma V, Panagariya A, Goel D. Clinical and radiological profile of 122 cases of idiopathic intracranial hypertension in a tertiary care centre of India: an observational study. Neurol India. 2022;70(2):704–709. doi:10.4103/0028-3886.344644.
  • Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–1165. doi:10.1212/WNL.0b013e3182a55f17.
  • Mollan SP, Chong YJ, Grech O, Sinclair AJ, Wakerley BR. Current perspectives on idiopathic intracranial hypertension without papilloedema. Life (Basel). 2021;11(6). doi:10.3390/life11060472.
  • R Core Team. R: a language and environment for statistical computing [Online]. https://www.R-project.org/.
  • Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48. doi:10.18637/jss.v067.i01.
  • Vijay V, Mollan SP, Mitchell JL, et al. Using optical coherence tomography as a surrogate of measurements of intracranial pressure in idiopathic intracranial hypertension. JAMA Ophthalmol. 2020;138(12):1264–1271. doi:10.1001/jamaophthalmol.2020.4242.
  • Mitchell JL, Lyons HS, Walker JK, et al. The effect of exenatide on intracranial pressure in idiopathic intracranial hypertension: a randomised clinical trial. Brain. 2023;146:1821–1830. doi:10.1093/brain/awad003.
  • Mollan SP, Hornby C, Mitchell J, Sinclair AJ. Evaluation and management of adult idiopathic intracranial hypertension. Pract Neurol. 2018;18(6):485–488. doi:10.1136/practneurol-2018-002009.
  • Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ. The expanding burden of idiopathic intracranial hypertension. Eye (Lond). 2019;33(3):478–485. doi:10.1038/s41433-018-0238-5.
  • Chen BS, Newman NJ, Biousse V. Atypical presentations of idiopathic intracranial hypertension. Taiwan J Ophthalmol. 2021;11(1):25–38. doi:10.4103/tjo.tjo_69_20.
  • Thaller M, Wakerley BR, Abbott S, Tahrani AA, Mollan SP, Sinclair AJ. Managing idiopathic intracranial hypertension in pregnancy: practical advice. Pract Neurol. 2022;22(4):295–300. doi:10.1136/practneurol-2021-003152.
  • Aguiar M, Frew E, Mollan SP, et al. The health economic evaluation of bariatric surgery versus a community weight management intervention analysis from the idiopathic intracranial hypertension weight trial (IIH:WT). Life (Basel). 2021;11(5):409. doi:10.3390/life11050409.
  • Saxena P, Prakash A, Nigam A, Mishra A. Polycystic ovary syndrome: is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index. Indian J Endocrinol Metab. 2012;16:996–999. doi:10.4103/2230-8210.103011.
  • Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab. 1997;82:4075–4079. doi:10.1210/jc.82.12.4075.
  • Glueck CJ, Golnik KC, Aregawi D, Goldenberg N, Sieve L, Wang P. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. Transl Res. 2006;148:215–222. doi:10.1016/j.trsl.2006.05.003.
  • Toosy S, Sodi R, Pappachan JM. Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach. J Diabetes Metab Disord. 2018;17(2):277–285. doi:10.1007/s40200-018-0371-5.
  • Laurie SS, Lee SMC, Macias BR, et al. Optic disc edema and choroidal engorgement in astronauts during spaceflight and individuals exposed to bed rest. JAMA Ophthalmol. 2020;138(2):165–172. doi:10.1001/jamaophthalmol.2019.5261.
  • Scott RA, Tarver WJ, Brunstetter TJ, Urquieta E. Optic nerve tortuosity on earth and in space. Aerosp Med Hum Perform. 2020;91:91–97. doi:10.3357/AMHP.5406.2020.
  • Mollan SP, Bodoza S, Ni Mhealoid A, et al. Visual field pointwise analysis of the idiopathic intracranial hypertension weight trial (IIH:WT). Transl Vis Sci Technol. 2023;12:1. doi:10.1167/tvst.12.5.1.
  • Mollan SP, Fraser CL, Digre KB, et al. Guidelines of the international headache society for controlled clinical trials in idiopathic intracranial hypertension. Cephalalgia. 2023;43(8):3331024231197118. doi:10.1177/03331024231197118.
  • Mollan SP, Momin SNA, Khatkar PS, Grech O, Sinclair AJ, Tsermoulas G. A neuro-ophthalmologist’s guide to advances in intracranial pressure measurements. Eye Brain. 2023;15:113–124. doi:10.2147/EB.S404642.
  • Scotton WJ, Mollan SP, Walters T, et al. Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey. BMJ Open. 2018;8(5):e020445. doi:10.1136/bmjopen-2017-020445.
  • Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19(1):93. doi:10.1186/s10194-018-0919-2.